Wegovy can also increase the risk of acute pancreatitis, gallbladder problems, low blood sugar, kidney problems, increased heart rate, diabetic eye complications, and suicidal ideation
Growth hormone (GH), GH receptor, and signal transduction
It mainly lowers fasting blood sugar levels by inhibiting the livers ability to produce glucose
Key Preclinical Study (Neelakantan et al., 2018): Treatment in diet-induced obese mice produced progressive body weight loss, reduced white adipose tissue mass and adipocyte size, decreased total cholesterol, and no changes in food intake effects were metabolic, not appetite-driven
1998 (a small double-blind crossover for erectile dysfunction) constitute the sum total of controlled human research